Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,670 | 5,024 | 4,288 | 6,677 | 9,055 |
| Receivables | 1,045 | 1,046 | 1,044 | 32 | 32 |
| TOTAL | $3,226 | $6,627 | $6,041 | $7,591 | $9,679 |
| Non-Current Assets | |||||
| PPE Net | 189 | 206 | 248 | 300 | 359 |
| Other Non-Current Assets | 432 | 553 | 671 | 1,795 | 1,940 |
| TOTAL | $621 | $759 | $919 | $2,095 | $2,299 |
| Total Assets | $3,847 | $7,386 | $6,960 | $9,686 | $11,978 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 621 | 1,021 | 671 | 580 | 673 |
| Accrued Expenses | 738 | 981 | 818 | 771 | 727 |
| Other current liabilities | 218 | 336 | 453 | 570 | 218 |
| TOTAL | $1,893 | $2,785 | $2,475 | $2,449 | $2,142 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,300 | 5,700 | 44 | 172 | 298 |
| TOTAL | $4,300 | $5,700 | $44 | $172 | $298 |
| Total Liabilities | $6,193 | $8,485 | $2,519 | $2,621 | $2,440 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,851 | 3,494 | 2,608 | 2,608 | 2,600 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -357,338 | -356,000 | -350,236 | -347,545 | -345,000 |
| TOTAL | $-2,346 | $-1,099 | $4,441 | $7,065 | $9,538 |
| Total Liabilities And Equity | $3,847 | $7,386 | $6,960 | $9,686 | $11,978 |